My Cart [ 0 ]
New Products
New Services
Promotions
News
Home > Proteins & Peptides > A-Z Proteins
All natural and recombinant proteins.
    6292 A-Z Proteins Products
  • BP000083-GD26: Recombinant Human IFNα 2b Pegylated

    Source: E. coli-derived.
    The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^6 IU/mg.
    Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
    Endotoxin: < 0.1 ng/ug (1 EU/ug).

  • BP000087-GD24: Recombinant Human Interferon-gamma (IFNγ) Protein

    Source: E. coli-derived.
    The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be greater than 1.5 x 107 IU/ mg.
    Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
    Endotoxin: < 0.1 ng/ug (1 EU/ug).

  • BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein

    Source: E. coli-derived.
    The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
    Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
    Endotoxin: < 0.1 ng/ug (1 EU/ug).

  • BP000179-GD28: Recombinant Human Epidermal Growth Factor (EGF) Protein

    Source: E. coli-derived.
    Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
    Endotoxin: < 0.1 ng/ug (1 IEU/ug).

  • BP003061: Recombinant Human ACE2-His-Avi Protein (rhACE2-His)

    Source: mammalian cells.
    Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.

  • BP003055: Biotinylated Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (Spike Protein S1 Subunit)

    Source: mammalian cells.
    Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike S1-His-Avi protein at 1 ug/ml (100 ul/well). Dose response curve for the recombinant human ACE2-Fc fusion protein with the EC50 of 81 ng/ml determined by ELISA.
    Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.

  • BP003051: Biotinylated Recombinant SARS-CoV-2 Spike RBD-His-Avi (S1 RBD)

    Source: mammalian cells.
    Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike RBD-His-Avi protein at 1 ug/ml (100 ul/well). Dose response curve for the recombinant human ACE2-Fc fusion protein with the EC50 of 100 ng/ml determined by ELISA.
    Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.

  • BP003082: Recombinant Human CD319 / CRACC / SLAMF7 Protein

    Source: mammalian cells.
    Purity: > 95% by Bis-Tris PAGE and HPLC.

  • BP003082: Recombinant Human CD319 / CRACC / SLAMF7 Protein

    Source: mammalian cells.
    Purity: > 95% by Bis-Tris PAGE and HPLC.

  • BP002388-Z53: Recombinant Human Cellular tumor antigen p53 (p53) Protein

    Source: Baculovirus, SF9 insect cells-derived.
    Bioactivity test: 1 unit equals 1 nanogram of purified protein. 10 unit is sufficient for a gel mobility shift assay in a 20 ul reaction; 50 units are sufficient for reconstituted transcription assay and 100 units are sufficient for a protein-protein interaction assay.
    Purity: > 95%, by SDS-PAGE.
    Endotoxin Level: < 1.0 EU per 1 ug of the protein by the LAL method.

See our Privacy Policy